Federal Register / Vol. 65, No. 116 / Thursday, June 15, 2000 / Notices 37563

Audits conducted pursuant to 2 U.S.C.

437g, 438(b), and Title 26, U.S.C.

Matters concerning participation in civil

actions or proceedings or

arbitration.

Internal personnel rules and procedures

or matters affecting a particular

employee.

DATE & TIME: Thursday, June 22, 2000, at

10 a.m.

PLACE: 999 E Street, N.W., Washington,

D.C. (ninth floor).

STATUS: This meeting will be open to the

public.

ITEMS TO BE DISCUSSED: 

Correction and Approval of Minutes.

Draft Advisory Opinion 2000–10—

America’s Community Bankers

Political Action Committee

(COMPAC), Matthew D. Smyth,

Director.

Draft Advisory Opinion 2000–11—

Georgia-Pacific Corporation and the

G–P Employees Fund of GeorgiaPacific by counsel, Jan Witold

Baran.

Draft Advisory Opinion 2000–13—

iNEXTV Corporation by counsel,

John J. Duffy.

Administrative Matters.

PERSON TO CONTACT FOR INFORMATION:

Mr. Ron Harris, Press Officer,

Telephone: (202) 694–1220.

Mary W. Dove,

Acting Secretary of the Commission.

[FR Doc. 00–15267 Filed 6–13–00; 11:35 am]

BILLING CODE 6715–01–M

FEDERAL RESERVE SYSTEM

Formations of, Acquisitions by, and

Mergers of Bank Holding Companies

The companies listed in this notice

have applied to the Board for approval,

pursuant to the Bank holding company

Act of 1956 (12 U.S.C. 1841 et seq.)

(BHC Act), Regulation Y (12 CFR Part

225), and all other applicable statutes

and regulations to become a bank

holding company and/or to acquire the

assets or the ownership of, control of, or

the power to vote shares of a bank or

bank holding company and all of the

banks and nonbanking companies

owned by the bank holding company,

including the companies listed below.

The applications listed below, as well

as other related filings required by the

Board, are available for immediate

inspection at the Federal Reserve Bank

indicated. The application also will be

available for inspection at the offices of

the Board of Governors. Interested

persons may express their views in

writing on the standards enumerated in

the BHC Act (12 U.S.C. 1842(c)). If the

proposal also involves the acquisition of

a nonbanking company, the review also

includes whether the acquisition of the

nonbanking company complies with the

standards in section 4 of the BHC Act

(12 U.S.C. 1843). Unless otherwise

noted, nonbanking activities will be

conducted throughout the United States.

Additional information on all bank

holding companies may be obtained

from the National Information Center

website at www.ffiec.gov/nic/.

Unless otherwise noted, comments

regarding each of these applications

must be received at the Reserve Bank

indicated or the offices of the Board of

Governors not later than July 10, 2000.

A. Federal Reserve Bank of

Minneapolis (Jo Anne F. Lewellen,

Assistant Vice President), 90 Hennepin

Avenue, Minneapolis, Minnesota

55480–0291:

1. First Bancshares Corporation,

Gladstone, Michigan; to acquire 5.009,

for a total of 24.999 percent, of the

voting shares of Baybank Corporation,

Gladstone, Michigan, and thereby

indirectly acquire Baybank, Gladstone,

Michigan.

Board of Governors of the Federal Reserve

System, June 12, 2000.

Robert deV. Frierson,

Associate Secretary of the Board.

[FR Doc. 00–15172 Filed 6–14–00; 8:45 am]

BILLING CODE 6210–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[30DAY–43–00]

Agency Forms Undergoing Paperwork

Reduction Act Review

The Centers for Disease Control and

Prevention (CDC) publishes a list of

information collection requests under

review by the Office of Management and

Budget (OMB) in compliance with the

Paperwork Reduction Act (44 U.S.C.

chapter 35). To request a copy of these

requests, call the CDC Reports Clearance

Officer at (404) 639–7090. Send written

comments to CDC, Desk Officer; Human

Resources and Housing Branch, New

Executive Office Building, Room 10235;

Washington, DC 20503. Written

comments should be received within 30

days of this notice.

Proposed Projects

1. Survery of Laboratory Practices for

Mycobacterium tuberculosis Drug

Susceptibility Testing in the U.S.—

New—As part of the continuing effort to

support public health objectives of

treatment, disease prevention and

surveillance programs, the Public

Health Practice Program Office

(PHPPO), Centers for Disease Control

and Prevention (CDC) seeks to collect

information from both public health and

private sector laboratories performing

drug susceptibility testing on

Mycobacterium tuberculosis.

Tuberculosis is a continuing public

health problem in the United States

despite declining case rates. Although

public health efforts have brought multi

drug resistant tuberculosis (MDRTB)

under control, these MDRTB and other

drug resistant isolates will continue to

challenge laboratory support for TB

control because of higher prevalence

rates and potential for transmission in

some segments of the U.S. population.

To control this health problem, it is

imperative that cases of tuberculosis are

identified and placed on effective

chemotherapy as quickly as possible.

Information collected in the survey will

be on test methods, drug concentrations,

quality assurance, quality control and

reporting practices. The survey will also

collect information regarding the type of

laboratories where testing is performed,

the number of tests performed, testing

for primary or secondary antituberculosis drugs and turnaround time

for reporting susceptibility test results to

the clinician and public health

programs. This survey will provide CDC

with information to facilitate standard

use of drugs and concentrations tested,

interpretation of test results, and

laboratory reports so that the

information for the clinician is

consistent regardless of the laboratory

performing testing. This 25-question

survey will be mailed to 200

laboratories which are directly involved

in Mycobacterium tuberculosis

susceptibility drug testing. The amount

of time required for completion of the

survey will be 30–45 minutes for each

respondent. The only cost to the

respondent is the time involved in

completion of the survey. Results of the

survey will be published in a peerreviewed journal and shared at national

meetings to encourage the adoption of

standard practices. The estimated

annualized burden for this project is 150

hours.

37564 Federal Register / Vol. 65, No. 116 / Thursday, June 15, 2000 / Notices

Respondents Number of respondents

Number of responses/respondent

Average burden per response

(in hours)

Laboratories ................................................................................................................................. 200 1 45/60

Dated: June 8, 2000.

Nancy Cheal,

Acting Associate Director for Policy, Planning

and Evaluation, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 00–15114 Filed 6–14–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[30DAY–46–00]

Agency Forms Undergoing Paperwork

Reduction Act Review

The Centers for Disease Control and

Prevention (CDC) publishes a list of

information collection requests under

review by the Office of Management and

Budget (OMB) in compliance with the

Paperwork Reduction Act (44 U.S.C.

chapter 35). To request a copy of these

requests, call the CDC Reports Clearance

Officer at (404) 639–7090. Send written

comments to CDC, Desk Officer; Human

Resources and Housing Branch, New

Executive Office Building, Room 10235;

Washington, DC 20503. Written

comments should be received within 30

days of this notice.

Proposed Projects

Possible Estuary-Associated

Syndrome (PEAS) Surveillance—

Extension—National Center for

Environmental Health (NCEH)—In 1997,

scientists found a newly identified

microorganism, the dinoflagellate

Pfiesteria piscicida, in water samples

taken from a bay tributary. The presence

of large numbers of this organism (a

bloom) was purportedly associated with

observations of thousands of dead fish

as well as with reports of a wide range

of adverse human health effects. Reports

of this purported association created

excessive public concern about

exposure to estuarine waters and a

general distrust in seafood that

prompted a flood of inquiries to public

health and environmental quality

agencies.

Since 1997, the Centers for Disease

Control and Prevention (CDC) has been

working with the States of Delaware,

Florida, Maryland, North Carolina,

South Carolina, and Virginia in a series

of meetings, workshops, and conference

calls to design, implement, evaluate,

and revise surveillance activities to

provide a quantitative estimate of the

public health burden associated with

responding to Pfiesteria-related events,

including blooms, fish kills, and people

with health complaints. Cooperative

agreement funds were awarded to these

states to develop a multi-state

surveillance system to examine the

effects of Pfiesteria blooms upon

humans and to expand the scientific

knowledge of the human health effects

of Pfiesteria. Specifically, the states will

quantify the burden of PEAS on their

health agencies by enumerating the

number of contacts involving public and

professional requests for information as

well as symptoms involved in selfreporting. In collaboration with the state

health departments, NCEH has

developed a standardized data

collection instrument that the states

may use to collect and store the

surveillance data. NCEH has requested

that the states report specific data

elements back at regular intervals so

that NCEH can compile the data and

issue periodic aggregate reports. CDC/

NCEH is requesting a 3-year clearance.

The total annual burden hours are 99.

Type of burden Number of respondents

Number of responses

Average burden/response

(in hours)

Information only calls ................................................................................................................... 800 1 5/60

Symptomatic Reports—telephone interview ................................................................................ 80 1 25/60

Dated: June 8, 2000.

Nancy Cheal,

Acting Associate Director for Policy, Planning

and Evaluation, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 00–15115 Filed 6–14–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[Announcement Number 00127]

Developing a Model System for the

Collection, Analysis, and

Dissemination of Data on Genetic

Tests, Notice of Availability of Funds;

Amendment

A notice announcing the availability

of Fiscal Year 2000 funds to fund a

cooperative agreement program for

Developing a Model System for the

Collection, Analysis, and Dissemination

of Data on Genetic Tests, which was

published in the Federal Register on

June 8, 2000, (Vol. 65, No. 111, Pages

36446–36448). The notice is amended as

follows:

On page 36447, First Column, under

Section D. Program Requirements, Item

1(c), change to read: Using experts,

identify six to ten DNA-based tests to

guide in the finding, collection, and

analysis of relevant data (published and

unpublished).

On page 36447, Third Column, under

Section G. Evaluation Criteria, Item 4(c),

change to read: Identify available data

for the DNA-based tests, identifying data

gaps, and developing common data

formats,